Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution

被引:46
作者
Lee, Chang Young [1 ]
Bae, Mi Kyung [1 ]
Park, In Kyu [1 ]
Kim, Dae Joon [1 ]
Lee, Jin Gu [1 ]
Chung, Kyung Young [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
关键词
Thymic carcinoma; Masaoka stage; Complete resection; Prognostic factor; EPITHELIAL TUMORS;
D O I
10.1016/j.ejcts.2009.02.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Prognosis of primary thymic carcinomas is poor due to advanced stage progression at diagnosis and highly malignant behavior. We retrospectively evaluated patients with thymic carcinoma to determine the prognostic factors. Methods: Sixty patients diagnosed and treated for thymic carcinoma from 1986 to 2005 were reviewed retrospectively. Influences of demographic characteristics, Masaoka stage, histologic grade, completeness of resection and adjuvant treatment on survival were evaluated. We defined complete resection as macroscopically and microscopically total resection of a tumor (R0 resection) and incomplete resection was subdivided into microscopic incomplete resection (R1 resection) or macroscopically incomplete resection (112 resection). Results: There were 42 mate and 18 female patients and mean age was 53.9 (+/- 14.4) years old. The 5-year overall survival rate was 38.8% and median survival time was 35.6 months. The most common histologic type was squamous cell carcinoma (n = 29). In our study, 5 patients (8.3%) were in Masaoka stage 1, 5 (8.3%) were in stage 11, 19 (31.7%) were in stage III, 15 (25.0%) were stage in IVa, and 16 (26.7%) were in stage IVb. Among 40 patients who underwent surgical resection, complete resection was achieved in 14 patients. The 5-year survival rate after complete resection was 85.1% and was considered significantly better than those after incomplete resection (29.0%, p = 0.001) and non-surgical treatment (16.7%, p < 0.001). But, no survival difference could be found between the incomplete resection group and non-surgical treatment group (p = 0.15). The 5-year survival rates of early Masaoka stage patients were significantly higher than advanced Masaoka stage (90.0% vs 28.3%, p = 0.001). The recurrence rates within 3 years after R1 resection (75.0%) were significantly higher than that after R0 resection (14.9%, p = 0.008). Conclusions: In thymic carcinoma, complete resection of early Masaoka stage lesions is the most important factor for disease control and long-term survival of patients. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 18 条
[1]   Thymic carcinoma: Current staging does not predict prognosis [J].
Blumberg, D ;
Burt, ME ;
Bains, MS ;
Downey, RJ ;
Martini, N ;
Rusch, V ;
Ginsberg, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (02) :303-308
[2]   Thymic carcinoma - Analysis of nineteen clinicopathological studies [J].
Chung, DA .
THORACIC AND CARDIOVASCULAR SURGEON, 2000, 48 (02) :114-119
[3]   THYMIC CARCINOMA - 10 YEARS EXPERIENCE IN 20 PATIENTS [J].
HSU, CP ;
CHEN, CY ;
CHEN, CL ;
LIN, CT ;
HSU, NY ;
WANG, JH ;
WANG, PY .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) :615-620
[4]   Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors - A clinicopathologic study of 108 patients and literature review [J].
Kim, DJ ;
Yang, WI ;
Choi, SS ;
Kim, KD ;
Chung, KY .
CHEST, 2005, 127 (03) :755-761
[5]   Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan [J].
Kondo, K ;
Monden, Y .
ANNALS OF THORACIC SURGERY, 2003, 76 (03) :878-884
[6]  
MASAOKA A, 1981, CANCER-AM CANCER SOC, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO
[7]  
2-R
[8]  
Moriyama S, 1989, Nihon Kyobu Geka Gakkai Zasshi, V37, P717
[9]   Treatment and prognosis of thymic carcinoma - A retrospective analysis of 40 cases [J].
Ogawa, K ;
Toita, T ;
Uno, T ;
Fuwa, N ;
Kakinohana, Y ;
Kamata, M ;
Koja, K ;
Kinjo, T ;
Adachi, G ;
Murayama, S .
CANCER, 2002, 94 (12) :3115-3119
[10]  
SENSAKI K, 1993, RESPIRATION, V60, P247